On this page ▾
Key takeaways
- Researchers protected inner ear hair cells in mice that lack a working CLIC5 gene.
- It was an animal study published in 2025, so there are no human results yet.
- A self-complementary AAV vector worked as well as a standard one at a lower dose.
- Genetic factors cause up to 60% of congenital and early-onset hearing loss, according to NIDCD.
- Hearing aids and cochlear implants remain the usual options for permanent hearing loss.
Researchers at Tel Aviv University and in the US have used gene therapy to protect the inner ear’s hair cells in mice that lack a working CLIC5 gene. The treatment preserved both hearing and balance in the animals1. It has not been tested in people, and no gene therapy for CLIC5 hearing loss is available.
The work, led by Professor Karen Avraham of Tel Aviv University with collaborators at Boston Children’s Hospital and Harvard Medical School, was published in EMBO Molecular Medicine in 2025. The CLIC5 gene helps keep the hair cells that enable hearing and balance stable.
How common is genetic hearing loss?
The World Health Organization projects that nearly 2.5 billion people will have some degree of hearing loss by 2050, and more than 700 million will need hearing rehabilitation2. Genetic factors cause up to 60% of congenital and early-onset hearing loss3.
Balance problems that start in the inner ear can also make everyday life harder. Current treatments such as hearing aids and cochlear implants help people hear but do not stop the hair cells being lost. A therapy that works at the genetic level might one day change long-term outcomes for some people, if it proves safe and effective in humans.
How does the CLIC5 gene therapy work?
The CLIC5 gene supports the structure of the hair cells that enable hearing and balance. When the gene is faulty, these cells deteriorate, causing hearing loss first and balance problems later.
The new therapy uses a self-complementary adeno-associated virus (scAAV) to deliver a healthy copy of the gene. In mice, it worked as well as a conventional single-stranded vector at a lower dose, prevented hair cell degeneration and preserved both hearing and balance1.
What could this mean for people?
Because the inner ear’s hearing and balance systems share vulnerable cell structures, a therapy that stabilises hair cells might one day help prevent or delay both sensorineural hearing loss and balance disorders linked to CLIC5. That is a hope, not a result: it has not been shown in people.
If it works in humans, early treatment could matter most for children born with these genetic changes, but researchers would first need to show it is safe and effective. For now, hearing aids and cochlear implants are the usual options for permanent hearing loss4. You can read about the first gene therapy approved for a genetic form of deafness in our article on DB-OTO gene therapy, and about the wider gene therapy research.
What do audiologists say?
“This work presents an exciting possibility in a growing body of research into stem cell and genetic therapies for hearing loss,” said Micaela Stonestreet, a Clinical Audiologist at Hearology. “If similar results emerge in human trials, we could see a meaningful shift from managing symptoms to preventing progression.”
If you are worried about your hearing today, a hearing test is the first step, and the right help depends on the cause.

Frequently asked questions
What is the latest treatment for hearing loss?
Will there be a cure for hearing loss in the future?
Is there gene therapy for hearing loss?
What is the CLIC5 gene?
References:
- [1] R. Hahn, S. Taiber, O. Shubina-Oleinik, G. S. G. Géléoc, J. R. Holt, and K. B. Avraham, "AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness," EMBO Molecular Medicine, vol. 17, no. 9, pp. 2233-2257, Sep. 2025, doi: 10.1038/s44321-025-00275-7. [Online]. Available:
- [2] World Health Organization, "Deafness and hearing loss," WHO fact sheet. Accessed: Nov. 15, 2026. [Online]. Available:
- [3] National Institute on Deafness and Other Communication Disorders, "The future of gene therapy for hearing loss," NIDCD. Accessed: Nov. 15, 2026. [Online]. Available:
- [4] NHS, "Hearing loss," NHS website. Accessed: Nov. 15, 2026. [Online]. Available:

